Valo is a technology company transforming the drug discovery and development process using its Opal Platform, human-centric data, and AI-powered compute.
Lexington, MA
Joined September 2020
- Tweets232
- Following70
- Followers584
- Likes144
Pinned Tweet
We're #hiring! Take a look at our open roles and see if you might be the right fit or refer a friend. We're excited about the year ahead and are focused on our mission to propel drug discovery and the development of innovative medicines. Join us! valohealth.com/company/caree…
We’re proud to share that Valo has been named a "Best Place to Work" by the @BosBizJournal! This recognition reflects the intentional culture and ways of working we’ve built together. Learn more about life at Valo: lnkd.in/e83uC5B3
Proud to announce the appointment Chris Anagnostopoulos, PhD, C.Stat, to the newly created position of Chief Causal AI Officer. Chris is a seasoned AI and life sciences innovation leader who will lead the advancement of our human causal biology platform.
valohealth.com/press/valo-he…
We’re proud to announce that Dr. Karin Conde-Knape will join Valo as Chief Scientific Officer!
This appointment follows the planned retirement of our current CSO, Dr. Mike Graziano, who has been instrumental in advancing Valo's science and platform.
valohealth.com/press/valo-he…
At Valo, biology, chemistry, and engineering don’t just collaborate, they’re intentionally integrated into a connected discovery model.
Learn more about how our integrated approach is reshaping #DrugDiscovery: valohealth.com/approach
We’re proud to announce that Rita Kale has joined Valo as Chief Financial Officer!
Rita brings two decades of global finance expertise, a track record of scaling organizations, and a commitment to driving innovation for patients.
valohealth.com/press/valo-he…
We’re proud to announce our new collaboration with Merck KGaA, Darmstadt, Germany, to accelerate drug discovery in Parkinson’s Disease and related neurological disorders.
Learn more about this collaboration here: valohealth.com/press/valo-he…
Valo Health retweeted
𝐀𝐈 𝐍𝐞𝐰𝐬: Brian Alexander, former CEO of Foundation Medicine, describes how @ValoHealth is using its AI expertise to partner with companies and foundations on discovery and development projects.
Full video: biotechtv.com/post/brian-ale…
We’re proud to work with @MichaelJFoxOrg to advance our collective understanding of Parkinson’s Disease, aiming to pave a promising path for therapeutic discovery. valohealth.com/press/valo-he…
Honored to receive a grant from the @MichaelJFoxOrg's Targets to Therapies initiative. This is an exciting opportunity to use robust human data sets and advanced analytical tools to deepen our understanding of Parkinson’s disease. valohealth.com/press/valo-he…
Science Day at Valo was a huge success! Our biology, chemistry, and engineering teams came together to share their groundbreaking work, tackle new challenges, and build connections across the organization.
More about life at Valo: valohealth.com/company/caree…
New technologies like AI require new ways of working. Having highly experienced drug developers & cutting-edge technology developers working side-by-side allows us to deeply understand the problems we're solving, so we can create tailored solutions together.
"At the end of the day, we're all part of an ecosystem. And if we can find new targets, make new drugs of those targets, and get them out to patients as quickly as possible, everybody wins.” More on Valo's approach to drug discovery & partnering strategy:
bizjournals.com/boston/news/…
At Valo Health, we do drug discovery differently. We use real world data and advanced analytical tools to create a rapid learning environment and maximize knowledge generation.
More about our unique approach to drug discovery: linkedin.com/pulse/industria…
We’re committed to learning faster and in new ways, serving as a dynamic R&D engine with our partners.
We look forward to connecting with organizations who are ready to build the future of drug discovery and development at #BIO2025.
valohealth.com/
Recent research published in Toxicological Sciences, in collaboration with @Takeda, demonstrates how 3D cardiac tissues, built leveraging the Opal Computational Platform™, better predict how the heart responds to new therapies.
More here: academic.oup.com/toxsci/adva…
Today @PioneeringMeds and @pfizer announced they will leverage Logica® to accelerate the development of therapeutics for autoimmune diseases. It's another example of how we partner to drive innovation in drug discovery with @CRiverLabs. For more: valohealth.com/press/flagshi…
Today, @CRiverLabs announced that Logica® identified a product candidate for the treatment of different forms of lupus & other autoimmune conditions.
Our collaboration with @CRiverLabs uses the AI-powered Opal Computational Platform™.
Learn more: valohealth.com/press/charles…
We are pleased to introduce Peggy Dalicandro as our VP, Head of Human Resources. Peggy has already added so much value to our growing team & we are excited to have her experience and enthusiasm.
Learn more about Peggy: valohealth.com/press/valo-he…
#HumanResources #TalentAcquisition
With @_nference, we are maximizing our ability to discover and develop new drug targets. This collaboration will provide rich real-world data and analytics tools to support our human-centric approach to advancing precision medicines. Read more: valohealth.com/press/valo-he…
Exciting news from @FlagshipPioneer on the raise of $3.6 billion to fuel breakthrough innovations that transform human health and sustainability. Valo is proud to be #FlagshipFounded and part of an ecosystem taking bold scientific leaps to deliver a better future for all.
Flagship Pioneering raises $3.6 billion to fuel critical breakthroughs in human health and sustainability. This expanded capital pool will accelerate the impact of original science and the creation and development of an estimated 25 breakthrough companies in human health, sustainability, and artificial intelligence. Hear from Flagship Founder and CEO @NoubarAfeyan about how we're taking #BiggerLeaps by leveraging the power of generative AI, forging novel partnerships with pharma to speed drug development, expanding globally, and promoting and hiring top talent to our leadership ranks. Read the full press release: bit.ly/4eQfx05